Body surface area and body weight predict total liver volume in Western adults by Abdalla, Eddie et al.
Body Surface Area and Body Weight Predict Total Liver
Volume in Western Adults
Jean-Nicolas Vauthey,* Eddie K. Abdalla,* Dorota A. Doherty,† Philippe Gertsch,‡
Marc J. Fenstermacher,§ Evelyne M. Loyer,§ Jan Lerut, Roland Materne,¶
Xuemei Wang,† Arthur Encarnacion,* Delise Herron,§ Christian Mathey,#
Giovanni Ferrari,‡ Chuslip Charnsangavej,§ Kim-Anh Do,† and Alban Denys#
Computed tomography (CT) is used increasingly to mea-
sure liver volume in patients undergoing evaluation for
transplantation or resection. This study is designed to
determine a formula predicting total liver volume (TLV)
based on body surface area (BSA) or body weight inWest-
ern adults. TLV was measured in 292 patients from four
Western centers. Liver volumes were calculated from heli-
cal computed tomographic scans obtained for conditions
unrelated to the hepatobiliary system. BSA was calculated
based on height and weight. Each center used a different
established method of three-dimensional volume recon-
struction. Using regression analysis, measurements were
compared, and formulas correlating BSA or body weight
to TLV were established. A linear regression formula to
estimate TLV based on BSA was obtained: TLV 
794.41  1,267.28  BSA (square meters; r2  0.46;
P < .0001). A formula based on patient weight also was
derived: TLV  191.80  18.51  weight (kilograms;
r2  0.49; P < .0001). The newly derived TLV formula
based on BSA was compared with previously reported
formulas. The application of a formula obtained from
healthy Japanese individuals underestimated TLV. Two
formulas derived from autopsy data for Western popula-
tions were similar to the newly derived BSA formula, with
a slight overestimation of TLV. In conclusion, hepatic
three-dimensional volume reconstruction based on helical
CT predicts TLV based on BSA or body weight. The new
formulas derived from this correlation should contribute
to the estimation of TLV before liver transplantation or
major hepatic resection. (Liver Transpl 2002;8:233-240.)
In the past decade, the role of computed tomography(CT) has extended beyond its use for liver imaging to
include three-dimensional volumetric measurement
before liver transplantation or major hepatic resec-
tion.1-4 This has been possible because of a close corre-
lation between the volume obtained by three-dimen-
sional reconstruction of computed tomographic images
and actual liver volume.5
In a recent Japanese study, a formula that enables
calculation of total liver volume (TLV) from body sur-
face area (BSA) was generated after study of CT-based
three-dimensional volumetric measurement of livers of
children and adults. This formula has been applied to
calculate the graft to TLV ratio for living related donor
liver transplantation4,6 and the future liver remnant
(FLR) to TLV ratio before liver resection.2 However,
the formula has not gained general acceptance at West-
ern centers, and its accuracy has been questioned
because of Western autopsy measurements that indicate
on average a TLV of 323 cm3 greater than expected
based on the Japanese formula.7 In addition, body
weight, rather than BSA, has been used to estimate graft
volume before liver transplantation, particularly donor-
recipient weight ratio.8-10 However, to our knowledge,
the correlation between body weight and TLV has not
been evaluated.
In addition to the issue of liver size match, the goal of
preoperative liver volume estimation is to estimate
hepatic metabolic demands of an individual patient.11
Thus, a method that estimates appropriate volume
based on patient characteristics (e.g., patient weight or
BSA) in combination with a measure of liver volume
(by CT) is desirable. Although caloric needs, total body
water, and extracellular water correlate more closely to
BSA than body weight in children, differences are
minor.12,13 Therefore, either weight or BSA could pro-
vide a standard means to estimate liver function, as well
as size, before resection or transplantation.
We designed a multicenter study to evaluate the
correlation between TLV and BSA or body weight in
Western patients with normal livers who underwent
CT for conditions unrelated to the hepatobiliary sys-
tem. The newly derived formula based on BSA then was
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compared with existing formulas from Japan and West-
ern autopsy studies.
Materials and Methods
At four institutions in North America and Europe, TLV was
measured in 292 individuals who underwent helical CT for
conditions unrelated to the hepatobiliary system and who had
no known hepatic abnormality (cirrhosis, fibrosis, or steato-
sis). Patient age, height, and weight were recorded, and BSA
was calculated.14 Patients with conditions potentially affect-
ing the biliary tree (e.g., pancreas cancer) or associated with
diffuse liver disease (e.g., lymphoma) were excluded. Patients
who indicated that they were of African or Asian descent were
excluded. Each center used a different established method of
computed tomographic reconstruction, which depended on
available scanners and software (described next).
CT Method at Center 1
Liver volume was measured on an ISG Allegro workstation
(ISG Technologies Inc, Toronto, Canada) using a threshold
function. Source images were contiguous 7- or 10-mm helical
sections obtained during abdominal computed tomographic
scanning (General Electric HiSpeed; General Electric, Mil-
waukee, WI). To create a three-dimensional object using this
method, the liver was selected by the computer based on
specified density (pixel intensity) of the tissue (liver).
Unwanted contiguous areas (gallbladder and intrahepatic
inferior vena cava) were manually excluded using a computer
mouse-driven “cut” function for each computed tomographic
image. Three-dimensional volumes were created by summa-
tion of two-dimensional section areas multiplied by the slice
thickness.
CT Method at Center 2
At center 2, patients underwent abdominal helical computed
tomographic scans capturing transverse images at 5- or
10-mm intervals (Philips – CT – Spyro Tomoscan AV
Expander E 1, model 1997-98; Best, The Netherlands). In
this method, the computer mouse was used to outline the
perimeter of the liver (excluding the inferior vena cava and
gallbladder) on each slice, and the enclosed area was mea-
sured. Combining these measurements with the distance
between slices enabled three-dimensional reconstruction for
TLV calculation (Helax TMS, version 5; Uppsala, Sweden).
CT Method at Center 3
At center 3, computed tomographic images were acquired
using multicenter spiral CT (Lightspeed; General Electric,
Milwaukee, WI). Images were obtained using a 5-mm thick-
ness 60 seconds after injection of 100 mL of contrast medium
(Imagopaque 300; Nicomed, Princeton, NJ). Liver volumes
were calculated using an Advantage Windows workstation
(Advantage Windows, software version 3.1; General, Red-
mond, WA). Contours of the liver were delineated consecu-
tively on the screen, and volume was calculated by adding
each slice’s volume determined by the surface area, slice thick-
ness, and space between slices.
CT Method at Center 4
At center 4, volumes were calculated using the summation-
of-areas technique1 on an EasyVision workstation (n  26;
Philips Medical Systems, Best, The Netherlands) or an
MxView workstation (n  27; Marconi Medical Systems,
Cleveland, OH). The cross-sectional area of individual
images was calculated automatically after manually tracing
the perimeter of the liver with a computer mouse-driven sty-
lus. Volume was determined by multiplying the sum of all
areas by the image reconstruction interval.
Statistical Analysis
One-way analysis of variance models were used to test for
intercenter differences for all variables considered in analysis.
Linear regression analysis was used to predict TLV using body
indices (age and functions of weight and height) as candidate
predictors. BSA was calculated using Mosteller’s formula14:
BSA  (height [cm]  weight [kg]/3,600
Body mass index (BMI) was obtained by using the formula:
BMI weight (kilograms)/square height (meters).15
Subset analyses, with patients grouped by either sex or
center, also were performed to explore possible sex and center
effects. Simple regression models were fit to age, BMI, and
BSA. All multiple regressions excluded weight and height
measurements to avoid colinearity. Normality assumptions
about variables used in the model were checked by graphical
methods (Q-Q plots). Comparisons of TLV estimation for-
mulas used absolute deviation between TLVs predicted by the
model and actual TLV measured. Data analysis was per-
formed using SAS16 (SAS Institute Inc, Cary, NC) and
S-Plus17 (Data Analysis Products Division, Seattle, WA) sta-
tistical software.
Results
Descriptive statistics of age, weight, height, BSA, and
TLV for all subjects included in the estimation of TLV
are listed in Table 1. Patients’ mean ages and heights
differed significantly among all centers (P  .0001),
and mean patient weight in center 1 was significantly
different from those in centers 2, 3, and 4 (P .0001).
This was associated with a significant increase in mean
BSA of 1.94 m2 in center 1 compared with BSAs of
1.79, 1.83, and 1.76 m2 at centers 2, 3, and 4, respec-
tively (P .0001). Differences between TLV measure-
ments were found (P  .0001), with mean TLVs of
1,762 cm3 at center 1, 1,407 cm3 at center 2, 1,518 cm3
at center 3, and 1,380 cm3 at center 4.
Two linear regression models for TLV are listed in
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Table 2. The relationship between BSA and TLV was
consistent at all centers. The pooled-sample regression
for all centers combined was TLV  794.41 
1,267.28  BSA (r2  0.46; P .0001); this result is
shown graphically in Figure 1. When centers were con-
sidered separately, estimated r2 for centers 1, 2, 3, and 4
were 0.47, 0.41, 0.39, and 0.38, respectively (all P 
.0001).
Combining all four centers, the multiple regression
equation fitting TLV to age and BSA simultaneously
was TLV  695.81  1,279.38  BSA  2.26 
age (r2  0.47; P  .0001). However, when centers
were considered separately, particularly centers 2 and 3,
age was not significantly associated with TLV after
adjusting for BSA (P  .202 and P  .593, respec-
tively). Even when centers were combined, the partial
correlation coefficient of TLV after adjusting for BSA
was r2  0.01, indicating a negligible independent
effect of age on TLV. Age therefore was excluded from
the final formula. Exclusion of BMI from the TLV
regression model also was based on partial r2 analysis.
That BMI had no independent effect on TLV was con-
cluded when the partial correlation of TLV and BMI
after adjusting for BSA was estimated as r2  0.02.
An identical analysis using body weight rather than
BSA is listed in Table 3. The resulting formula derived
from data from all centers excluding patient age,
TLV  191.80  18.51  weight (r2  0.48; P 
.0001), is shown graphically in Figure 2. Existing for-
mulas for the estimation of TLV based on BSA were
compared with our formula. Figure 3 shows our regres-
sion line and the line for the Japanese population.1 The
two regression lines diverge as BSA increases, showing
the greatest difference in patients with a high BSA. On
average, the formula obtained using data from the Jap-
anese population underestimates TLV in our sample by
232.70  128.90 (SD) cm3. Our regression line was
compared (Figure 4) with the two previously reported
formulas obtained from autopsy data of Western pop-
ulations.7,18 The formula from Heinemann et al7 from
Germany, reporting on 1,332 “Caucasians,” overesti-
mates TLV in our sample by 91.88 44.69 (SD) cm3,
whereas the formula from DeLand and North18 from
the Johns Hopkins Hospital (which does not indicate
patient race) slightly overestimates TLV by 1.71 
74.20 (SD) cm3.
Discussion
In 1995, Urata et al1 proposed a formula to estimate
TLV based on BSA using computed tomographic
imaging for three-dimensional reconstruction of the
liver in 96 Japanese children and young adults. The
present study also uses computed tomographic volu-
metric measurements, but it indicates a different corre-
lation between BSA and TLV in this Western popula-
tion. Although the Japanese formula is derived from
measurements in a group of patients that is younger
with a smaller average BSA (in the majority, BSA 1.5
m2), the current study includes a larger cohort (292
patients), all of Western origin. Median age (56 years;
range, 14 to 90 years), weight (71 kg; range, 43 to 165
kg), and BSA (1.82 m2; range, 1.32 to 2.90 m2) reflect
the adult population likely to undergo hepatic surgery
in the West. The current formula is based on computed
tomographic measurements, and its validity is corrob-
orated by the close correlation with two formulas
derived from Western autopsy studies.7,18
This study was undertaken based on data showing
that computed tomographic volumetric analysis corre-
lates with actual liver volume.5,19,20 Previous studies
Table 1. Data Summary
Center Variable Mean Median Range
All
(n  292) Age (yr) 54 56 14-90
Weight (kg) 72 71 43-165
Height (cm) 169 169 118-192
BSA (m2) 1.84 1.82 1.32-2.90
BMI (kg/m2) 24.84 24.84 15.89-84.03
TLV (cm3) 1531 1487 649-3,558
Center 1
(n  74) Age (yr) 59 62 17-83
Weight (kg) 80 78 50-165
Height (cm) 171 172 118-192
BSA (m2) 1.94 1.92 1.48-2.90
BMI (kg/m2) 27.74 26.22 19.14-84.03
TLV (cm3) 1762 1669 944-3,558
Center 2
(n  63) Age (yr) 62 64 29-90
Weight (kg) 70 70 44-105
Height (cm) 165 163 150-185
BSA (m2) 1.79 1.81 1.38-2.22
BMI (kg/m2) 25.55 25.40 17.19-41.02
TLV (cm3) 1407 1369 649-2,030
Center 3
(n  102) Age (yr) 54 57 14-87
Weight (kg) 71 72 43-112
Height (cm) 170 170 146-187
BSA (m2) 1.83 1.85 1.32-2.31
BMI (kg/m2) 24.59 24.82 15.89-38.57
TLV (cm3) 1518 1481 911-2,729
Center 4
(n  53) Age (yr) 34 33 19-59
Weight (kg) 66 65 47-94
Height (cm) 169 170 154-192
BSA (m2) 1.76 1.74 1.43-2.21
BMI (kg/m2) 22.90 23.23 18.36-28.72
TLV (cm3) 1380 1378 865-1,900
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showed errors in computed tomographic volume calcu-
lation that included the partial-volume effect and respi-
ratory-phase and interobserver variation.5,21 However,
refinements in imaging techniques, the development of
helical CT, and the availability of sophisticated software
for three-dimensional reconstruction has improved
estimation accuracy to within 5%.1,22 In this study, the
high degree of correlation between TLV and BSA
obtained at four centers using four different CT scan-
ners and three-dimensional reconstruction techniques
reiterates the accuracy of computed tomographic vol-
ume measurement and shows that reliable results can be
obtained using different equipment and software.
This study confirms the known negative correlation
between age and TLV.23,24 However, this effect of age
on the correlation between BSA and TLV is negligible.
This finding facilitates comparison of the current for-
mula with other formulas and simplifies the calculation
of TLV in a clinical setting.
Liver grafts that are too small for the recipient can
compromise the results of transplantation.25,26 Size of
the liver graft has been estimated based on volume or
Figure 1. Correlation between
BSA and TLV (—; n  292)
showing the 95% confidence
interval (---) and 95% predic-
tive interval ().
Table 2. Linear Regression Models for TLV With BSA
No. of
Patients P r2
All centers
TLV  794.41  1,267.28 BSA 292 .0001 0.46
TLV  695.81  1,279.38 BSA  2.26  age .0001 0.47
Center 1
TLV  975.61  1,411.49 BSA 74 .0001 0.47
TLV  152.61  1,366.63 BSA  12.43  age .0001 0.55
Center 2
TLV  505.09  1,069.75 BSA 63 .0001 0.41
TLV  227.47  1,015.97 BSA  2.93  age* .0001 0.44
Center 3
TLV  570.79  1,143.30 BSA 102 .0001 0.39
TLV  530.90  1,151.81 BSA  1.02  age* .0001 0.40
Center 4
TLV  87.61  833.84  BSA 53 .0001 0.38
TLV  83.13  985.06  BSA  12.99  age .0001 0.48
*Models in which age is not a significant predictor of TLV.
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weight in the patient evaluation before living donor or
split-liver transplantation.4,21,26 Graft volume to stan-
dard liver volume values of 30% or less and graft weight
to body weight ratios less than 0.8 are associated with
increased morbidity and impaired patient and graft sur-
vival after transplantation. In these cases, ischemic
damage and rejection further compromise a small pre-
existing functional liver volume. The current study
indicates differences in TLV between Japanese and
Western adults, with TLV greater in Western patients
for the same BSA. Because weight also is used to calcu-
late BSA, the current study suggests that the graft
weight to body weight ratio method used in transplan-
tation studies may not allow for a direct comparison of
weight-based ratios between the East and West.
Estimation of TLV is necessary before major hepatic
resection that will leave a small FLR.2 In patients who
are candidates for resection of a hepatic lobe or more,
FLR size varies, and the safe minimal size for FLR is not
well defined.22,27 The standard technique for volumet-
ric measurement is based on radiographic measurement
of the whole liver, from which FLR can be deducted.
That formula includes resected volume, tumor volume,
and TLV: ([resected volume  tumor volume] 
Figure 2. Correlation between
weight and TLV (—; n 292)
showing the 95% confidence
interval (----) and 95% predic-
tive interval ().
Table 3. Linear Regression Models for TLV With Body Weight
No. of Patients P r2
All centers
TLV  191.80  18.51  weight 292 .0001 0.49
TLV  322.57  18.83  weight  2.88  age .0001 0.50
Center 1
TLV  202.05  19.42  weight 74 .0001 0.52
TLV  983.48  18.87  weight  12.45  age .0001 0.61
Center 2
TLV  318.09  15.53  weight 63 .0001 0.38
TLV  578.74  14.68  weight  3.25  age* .0001 0.40
Center 3
TLV  330.92  16.68  weight 102 .0001 0.39
TLV  396.05  16.95  weight  1.55  age* .0001 0.40
Center 4
TLV  432.26  14.33  weight 53 .0001 0.39
TLV  702.31  16.87  weight  13.04  age .0001 0.49
*Models in which age is not a significant predictor of TLV.
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[TLV tumor volume]). Multiple tumors and lesions
beyond the resolution of imaging may cause errors in
the estimation of resected functional liver volume. In
patients with bile duct tumors, measurement of the
compromised liver (because of bile duct dilatation,
cholangitis, or vascular obstruction) may not be rele-
vant using this formula.2,19,27,28
An alternate method of assessing the remnant liver
similar to the method used before transplantation,
which does not include tumor volume or resected vol-
ume, recently has been proposed. It is based on the
FLR-TLV ratio. FLR volume (which is not compro-
mised by tumor) is directly measured by computed
tomographic three-dimensional reconstruction. TLV is
calculated based on BSA. This alternate method allows
for a uniform comparison of FLR volume before
extended resection with or without preoperative portal
vein embolization. Based on this method of calculation,
a correlation between FLR volume and surgical out-
come has been established,2 supporting the use of a
formula for the determination of TLV that incorporates
patient characteristics (BSA or body weight) to generate
Figure 3. Regression line
obtained using data for 292
Western adults (—) and the
reference line for best-fit BSA
using the formula of Urata et
al1 (––).
Figure 4. Regression line
obtained using data for 292
Western adults (—) and refer-
ence line for best-fit BSA
using the autopsy data–de-
rived formulas of DeLand
and North18 (––) and Heine-
mann et al7 ().
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an estimate of liver function that allows for comparison
between patients.
It is important to recognize potential problems asso-
ciated with the application of the Japanese-derived for-
mula of Urata et al1 in Western patients. Because the
formula of Urata et al1 underestimates TLV in Western
patients, calculated TLV is 15% smaller on average for
the same BSA. This difference is clinically relevant
because a smaller TLV used as the denominator when
calculating the ratios of transplanted liver volume to
TLV or FLR volume to TLV will cause liver size to be
overestimated. Complications are more likely if either a
transplanted liver graft or an FLR after resection is too
small.2,3,25,26,29
Currently, FLR size and factors potentially compro-
mising liver function (cirrhosis or hepatitis and previ-
ous chemotherapy) are criteria by which patients are
selected for portal vein embolization.27,28,30 Small rem-
nant liver volumes after hepatectomy may negatively
influence outcome for different reasons. First, hepatic
reserve may be reduced because of preexisting liver dis-
ease, and the liver remaining after hepatectomy may not
provide sufficient function despite apparent adequate
volume. Second, the remaining volume of a normally
functioning liver may be insufficient, resulting in irre-
versible liver failure. The risk associated with hepatec-
tomy in patients with chronic liver disease has been
assessed by various liver function tests.31 Major hepa-
tectomy not only leads to parenchymal loss, but also
amputates the hepatic vascular bed, resulting in
increased portal pressure.32,33 Also, an increase in
hepatic portal resistance has been observed experimen-
tally during liver regeneration, which may further
aggravate functional recovery.34 Hepatic portal over-
flow has been considered a possible initiator of progres-
sive and irreversible liver insufficiency after hepatec-
tomy.35 Preoperative portal vein embolization has been
performed in selected patients to induce ipsilateral liver
atrophy and contralateral hypertrophy and thereby
reduce the risk for postoperative liver insufficiency. Pre-
operative portal vein embolization also may reduce the
risk for postoperative portal overflow.
Like other formulas for preresection or pretransplan-
tation liver volume calculation, the new formulas
should be considered estimates because of variability in
TLV correlation with body weight and BSA. Although
patients on our study had no known cirrhosis, fibrosis,
steatosis, biliary disease, or other liver disease to con-
found the analysis, a range of TLVs for a given BSA or
body weight was found. Steatosis as a reason for the
observed variability is unlikely given similar variations
in TLV at low and high weights or BSAs. The correla-
tion coefficient determined in the Western autopsy
study of Heinemann et al7 of more than 1,000 patients
(r2  0.30) similarly reflects this variability. Conse-
quently, some degree of overlap will exist; a proportion
of patients with small liver volumes will not experience
liver failure, whereas others with apparently adequate
volumes will experience complications associated with a
small liver remnant.
However, importantly, given the recognized value of
body weight and BSA in liver transplantation and resec-
tion,2,3,6,11,29 the newly described formulas may provide
a useful estimation of metabolic demands after major
liver surgery or transplantation in Western adults. In
cases of extended liver resection, TLV estimations may
contribute to better patient selection for preoperative
portal vein embolization.2 With the increasing use of
split-liver transplantation in adults,29 the two formulas
also could facilitate graft-recipient matching. Standard-
ized measurement techniques before resection and
transplantation will allow for comparisons between
centers so that the minimum required liver volume
necessary to avoid complications can be determined.
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